Suppr超能文献

抗酸剂与泼尼松同时给药:对泼尼松龙血清水平的影响。

Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.

作者信息

Tanner A R, Caffin J A, Halliday J W, Powell L W

出版信息

Br J Clin Pharmacol. 1979 Apr;7(4):397-400. doi: 10.1111/j.1365-2125.1979.tb00952.x.

Abstract

1 Specific radioimmunoassays have been developed for the measurement of prednisolone and prednisone in serum. 2 Serum prednisolone levels have been measured following the administration of prednisone both with and without antacids. 3 There were no significant differences in the values of Cmax (mean +/- s.d.) (251 +/- 80 ng/ml with, 245 +/- 69 ng/ml without antacid), AUC (1430 +/- 469 ng ml-1 h-1 with, 1406 +/- 530 ng ml-1 h-1 without antacid) or Tmax (1.6 +/- 0.6 h with, 1.6 +/- 0.8 h without antacid). 4 Serum prednisone levels were less than 20% of prednisolone levels at all time intervals in the subjects studied. 5 Concurrent antacid administration has no significant effect on serum prednisolone levels attained.

摘要
  1. 已开发出特定的放射免疫测定法来测量血清中的泼尼松龙和泼尼松。2. 在服用泼尼松时,无论是否同时服用抗酸剂,都对血清泼尼松龙水平进行了测量。3. Cmax(平均值±标准差)的值没有显著差异(服用抗酸剂时为251±80 ng/ml,未服用抗酸剂时为245±69 ng/ml),AUC(服用抗酸剂时为1430±469 ng ml-1 h-1,未服用抗酸剂时为1406±530 ng ml-1 h-1)或Tmax(服用抗酸剂时为1.6±0.6 h,未服用抗酸剂时为1.6±0.8 h)。4. 在所有研究的时间间隔内,受试者血清泼尼松水平均低于泼尼松龙水平的20%。5. 同时服用抗酸剂对所达到的血清泼尼松龙水平没有显著影响。

相似文献

引用本文的文献

7
Pharmacokinetics of intravenous and oral prednisolone.静脉注射和口服泼尼松龙的药代动力学
Br J Clin Pharmacol. 1980 Nov;10(5):503-8. doi: 10.1111/j.1365-2125.1980.tb01796.x.
9
Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone.
Eur J Clin Pharmacol. 1984;26(2):271-3. doi: 10.1007/BF00630299.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验